Benefits and risks of implantable cardioverter-defibrillators in children and young adults with congenital heart disease, primary electrical disease or paediatric cardiomyopathy
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf134 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Andrei Fetcu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Congenital and Pediatric Heart Surgery, German Heart Center Munich, University Hospital of Technische Universität München, Munich, Germ…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Heart Defects, Congenital, Cardiomyopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Förderverein des Deutschen Herzzentrums München.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
OBJECTIVES This study aimed to investigate the benefits and potential risks of implantable cardioverter-defibrillators in paediatric and congenital heart disease (CHD) patients in the current era. METHODS All patients with CHD, paediatric cardiomyopathy or primary electrical disease, who underwent implantation of a defibrillator from 2001 to 2023, were examined. The occurrence of appropriate therapy, unplanned surgeries due to device complications, inappropriate shocks and associated risk factors were analysed. RESULTS A total of 214 patients were included, with 61% having CHD, 17% having paediatric cardiomyopathy and 22% having primary electrical disease. The most common diagnoses were transposition of the great arteries and tetralogy of Fallot (each 12%). The median age at implantation was 23 years (interquartile ranges 15–38), and the median follow-up was 5.7 years (95% confidence interval 4.9—7.3). A total of 196 patients met the criteria for outcome analysis, where appropriate therapy was observed in 41% (n = 80), occurring more often in patients with indications for secondary prevention than primary prevention (56% vs 26% at 5 years, P = 0.003). The cumulative incidence of inappropriate shocks was 13% (n = 26), with patients with CHD being more frequently affected. Unplanned surgeries were required in 36% (n = 71), predominantly due to lead-related issues in those with abdominal generator placement. CONCLUSIONS The high rate of appropriate therapies underscores the critical importance of risk assessment in ICD selection, particularly to mitigate lead failures and unnecessary shocks. However, defibrillator therapy has a relevant rate of unplanned surgeries, with abdominal generators and epicardial/extracardiac leads being risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Congenital and Pediatric Heart Surgery, German Heart Center Munich, University Hospital of Technische Universität München, Munich, Germany.
- Division of Congenital and Pediatric Heart Surgery, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany.
- Europäisches Kinderherzzentrum München, Munich, Germany.
- Department of Cardiovascular Diseases, German Heart Center Munich, University Hospital of Technische Universität München, Munich, Germany.
- Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, University Hospital of Technische Universität München, Munich, Germany.
ORCID-Profile: Thibault Schaeffer, Paul Philipp Heinisch, Lena Friedrich, Alfred Hager, Peter Ewert, Masamichi Ono
Förderung
- Förderverein des Deutschen Herzzentrums München
Zitieren
APA
Fetcu, A., Schaeffer, T., Niedermaier, C., Palm, J., Osawa, T., Matsubara, M., Heinisch, P. P., Friedrich, L., Lennerz, C., Hager, A., Ewert, P., Hörer, J., & Ono, M. (2025). Benefits and risks of implantable cardioverter-defibrillators in children and young adults with congenital heart disease, primary electrical disease or paediatric cardiomyopathy. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf134
Vancouver
Fetcu A, Schaeffer T, Niedermaier C, Palm J, Osawa T, Matsubara M, et al. Benefits and risks of implantable cardioverter-defibrillators in children and young adults with congenital heart disease, primary electrical disease or paediatric cardiomyopathy. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf134
BibTeX
@article{Fetcu2025,
author = {Fetcu, Andrei and Schaeffer, Thibault and Niedermaier, Carolin and Palm, Jonas and Osawa, Takuya and Matsubara, Muneaki and Heinisch, Paul Philipp and Friedrich, Lena and Lennerz, Carsten and Hager, Alfred and Ewert, Peter and Hörer, Jürgen and Ono, Masamichi},
title = {Benefits and risks of implantable cardioverter-defibrillators in children and young adults with congenital heart disease, primary electrical disease or paediatric cardiomyopathy},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf134}
}
EUVIMED